Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Acura Pharmaceuticals Inc (NASDAQ:ACUR)

2.68
Delayed Data
As of 3:01pm ET
 -0.065 / -2.37%
Today’s Change
2.05
Today|||52-Week Range
6.75
+19.11%
Year-to-Date
No recent news for Acura Pharmaceuticals Inc.

Today’s Trading

Previous close2.75
Today’s open2.89
Day’s range2.49 - 3.07
Volume70,869
Average volume (3 months)50,533
Market cap$162.0M
Dividend yield--
Data as of 3:01pm ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)+6.90%
Earnings growth (this year)+81.48%
Earnings growth (next 5 years)--
Revenue growth (last year)+510.57%
P/E ratioNM
Price/Sales29.30
Price/Book26.54

Competitors

 Today’s
change
Today’s
% change
NEOTNeothetics Inc+0.11+0.93%
BITIBiotie Therapies Oyj+0.30+1.77%
RDHLRedhill Biopharma Lt...-0.09-0.70%
STMLStemline Therapeutic...+0.55+6.02%
Data as of 3:00pm ET, 08/28/2015

Financials

Next reporting dateNovember 3, 2015
EPS forecast (this quarter)$0.00
Annual revenue (last year)$751.0K
Annual profit (last year)-$13.2M
Net profit margin-1,758.85%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Robert B. Jones
CFO, Secretary, SVP &
Head-Investor Relations
Peter A. Clemens
Corporate headquarters
Palatine, Illinois

Forecasts

Partner Offers